Sort of a non event. - Sales stable to slightly higher - Just above breakeven profits. Incremental addition to cash which will help maintain abiity to buy back shares. - Still really need to get topline revenue numbers growing faster. - Stll very strong balance sheet and a value buy.
I didn't listen to the conference call. But I checked out the transcript.The guy from Accretive Capital really gave it to Chou at the end. He feels that if they can't get more out of the R&D than they are getting the company should just distribute the cash back to the shareholders. He's right.